These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34052464)

  • 21. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET.
    Brown AK; Kimura Y; Zoghbi SS; Siméon FG; Liow JS; Kreisl WC; Taku A; Fujita M; Pike VW; Innis RB
    J Nucl Med; 2008 Dec; 49(12):2042-8. PubMed ID: 19038998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revisiting the Radiosynthesis of [
    Varlow C; Murrell E; Holland JP; Kassenbrock A; Shannon W; Liang SH; Vasdev N; Stephenson NA
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.
    Sullivan JM; Lim K; Labaree D; Lin SF; McCarthy TJ; Seibyl JP; Tamagnan G; Huang Y; Carson RE; Ding YS; Morris ED
    J Cereb Blood Flow Metab; 2013 Apr; 33(4):532-41. PubMed ID: 23250105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [(18)F]FPEB and [(18)F]FDEGPECO comparative study of mGlu5 quantification in rodent brain.
    Kang JH; Lee M; Ryu YH; Lyoo CH; Kim CH; Lee KC; Choi TH; Choi JY
    Appl Radiat Isot; 2015 Apr; 98():103-7. PubMed ID: 25658029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study.
    Abdallah CG; Hannestad J; Mason GF; Holmes SE; DellaGioia N; Sanacora G; Jiang L; Matuskey D; Satodiya R; Gasparini F; Lin X; Javitch J; Planeta B; Nabulsi N; Carson RE; Esterlis I
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jul; 2(5):449-456. PubMed ID: 28993818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
    Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
    Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers.
    Hamill TG; Krause S; Ryan C; Bonnefous C; Govek S; Seiders TJ; Cosford ND; Roppe J; Kamenecka T; Patel S; Gibson RE; Sanabria S; Riffel K; Eng W; King C; Yang X; Green MD; O'Malley SS; Hargreaves R; Burns HD
    Synapse; 2005 Jun; 56(4):205-16. PubMed ID: 15803497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.
    Davis MT; Hillmer A; Holmes SE; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Angarita GA; Carson RE; Krystal JH; Esterlis I
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11490-11495. PubMed ID: 31085640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
    DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study.
    Brašić JR; Nandi A; Russell DS; Jennings D; Barret O; Martin SD; Slifer K; Sedlak T; Seibyl JP; Wong DF; Budimirovic DB
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.
    Kang Y; Henchcliffe C; Verma A; Vallabhajosula S; He B; Kothari PJ; Pryor KO; Mozley PD
    J Neuroimaging; 2019 Jan; 29(1):97-103. PubMed ID: 30230118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment.
    Wang J; Huang Q; He K; Li J; Guo T; Yang Y; Lin Z; Li S; Vanderlinden G; Huang Y; Van Laere K; Guan Y; Guo Q; Ni R; Li B; Xie F
    Alzheimers Dement; 2024 Jun; 20(6):3876-3888. PubMed ID: 38634334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.
    Crabbé M; Van der Perren A; Weerasekera A; Himmelreich U; Baekelandt V; Van Laere K; Casteels C
    Neurobiol Aging; 2018 Jan; 61():82-92. PubMed ID: 29055799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study.
    Leurquin-Sterk G; Ceccarini J; Crunelle CL; Weerasekera A; de Laat B; Himmelreich U; Bormans G; Van Laere K
    Addict Biol; 2018 May; 23(3):931-944. PubMed ID: 28884874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal imaging of metabotropic glutamate 5 receptors during early and extended alcohol abstinence.
    Hillmer AT; Angarita GA; Esterlis I; Anderson JM; Nabulsi N; Lim K; Ropchan J; Carson RE; Krystal JH; Malley SSO; Cosgrove KP
    Neuropsychopharmacology; 2021 Jan; 46(2):380-385. PubMed ID: 32919411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A gene.
    Brownell AL; Kuruppu D; Kil KE; Jokivarsi K; Poutiainen P; Zhu A; Maxwell M
    J Neuroinflammation; 2015 Nov; 12():217. PubMed ID: 26597638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo hippocampal cornu ammonis 1-3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes.
    Lam J; DuBois JM; Rowley J; Rousset OG; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Zimmermann M; Minuzzi L; Rosa-Neto P; Kobayashi E
    Epilepsia; 2021 Jul; 62(7):1559-1568. PubMed ID: 34060082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of [
    Krzyczmonik A; Grafinger KE; Keller T; Pfeifer L; Forsback S; Haaparanta-Solin M; Gouverneur V; López-Picón F; Solin O
    Nucl Med Biol; 2023; 116-117():108309. PubMed ID: 36521341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alcohol exposure on the glutamatergic system: a combined longitudinal
    de Laat B; Weerasekera A; Leurquin-Sterk G; Gsell W; Bormans G; Himmelreich U; Casteels C; Van Laere K
    Addict Biol; 2019 Jul; 24(4):696-706. PubMed ID: 29790622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.